{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:18:20Z","timestamp":1779243500718,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T00:00:00Z","timestamp":1311724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T00:00:00Z","timestamp":1311724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Articular tissues are capable of producing a range of eicosanoid mediators, each of which has individual biological effects and may be affected by anti-inflammatory treatment. We set out to develop and evaluate a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS) approach for the simultaneous analysis of multiple eicosanoid lipid mediators in equine synovial fluid (SF), and to illustrate its use for investigation of the <jats:italic>in vivo<\/jats:italic> effects of non-steroidal anti-inflammatory drug (NSAID) treatment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Synovial fluid samples were obtained from normal joints of 6 adult horses at baseline (0 hr) and at 8, 24 and 168 hours after experimental induction of transient acute synovitis, with horses treated once daily with oral NSAID (meloxicam, 0.6 mg\/kg) or placebo. Following solid-phase extraction, SF lipid mediator quantitation was based on liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS\/MS) analysis, and results were compared between disease states using linear discriminant analysis (LDA) and analysis of variance (ANOVA) with multiple comparisons corrections.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Of a total of 23 mediators targeted, 14 could be reliably identified and quantified in SF samples based on detection of characteristic fragment ions at retention times similar to those of commercial standards. LDA analysis of baseline, 8, 24 and 168 hour synovial fluid samples revealed a separation of these groups into discrete clusters, reflecting dynamic changes in eicosanoid release over the course of synovitis. Prostaglandin (PG) E<jats:sub>2<\/jats:sub> was significantly lower in NSAID vs. placebo treated samples at all time points; PGE<jats:sub>1<\/jats:sub>, 11-hydroxyeicosatetraenoic acid (11-HETE) and 13,14-dihydro-15keto PGF<jats:sub>2<\/jats:sub>\u03b1 were reduced at 8 and 24 hours by NSAID treatment; while 15-HETE, 6-keto PGF<jats:sub>1<\/jats:sub>\u03b1, PGF<jats:sub>2<\/jats:sub>\u03b1, 13,14-dihydro-15keto PGE<jats:sub>2<\/jats:sub> and thromboxane B<jats:sub>2<\/jats:sub> (TXB<jats:sub>2<\/jats:sub>) were reduced at the 8 hour time point only. An interesting pattern was seen for Leukotriene B<jats:sub>4<\/jats:sub> (LTB<jats:sub>4<\/jats:sub>), NSAID treatment causing an initial increase at 8 hours, but a significant reduction by 168 hours.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The described method allows a comprehensive analysis of synovial fluid eicosanoid profiles. Eicosanoid release in inflamed joints as well as differences between NSAID treated and placebo treated individuals are not limited to PGE<jats:sub>2<\/jats:sub> or to the early inflammatory phase.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3427","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T08:44:59Z","timestamp":1316508299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A targeted lipidomics approach to the study of eicosanoid release in synovial joints"],"prefix":"10.1186","volume":"13","author":[{"given":"Janny C","family":"de Grauw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris HA","family":"van de Lest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Ren\u00e9","family":"van Weeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,27]]},"reference":[{"key":"3185_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/joca.1999.0226","volume":"7","author":"LJ Crofford","year":"1999","unstructured":"Crofford LJ: COX-2 in synovial tissues. Osteoarthritis Cartilage. 1999, 7: 406-408. 10.1053\/joca.1999.0226.","journal-title":"Osteoarthritis Cartilage"},{"key":"3185_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI0215528","volume":"110","author":"JM McCoy","year":"2002","unstructured":"McCoy JM, Wicks JR, Audoly LP: The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest. 2002, 110: 651-658.","journal-title":"J Clin Invest"},{"key":"3185_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0049-0172(03)00134-3","volume":"33","author":"J Martel-Pelletier","year":"2003","unstructured":"Martel-Pelletier J, Pelletier JP, Fahmi H: Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum. 2003, 33: 155-167. 10.1016\/S0049-0172(03)00134-3.","journal-title":"Semin Arthritis Rheum"},{"key":"3185_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/01.bor.0000155363.61120.c3","volume":"17","author":"ES Molloy","year":"2005","unstructured":"Molloy ES, McCarthy GM: Eicosanoids, osteoarthritis, and crystal deposition diseases. Curr Opin Rheumatol. 2005, 17: 346-350. 10.1097\/01.bor.0000155363.61120.c3.","journal-title":"Curr Opin Rheumatol"},{"key":"3185_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/ncprheum0616","volume":"3","author":"S Yacoubian","year":"2007","unstructured":"Yacoubian S, Serhan CN: New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007, 3: 570-579. 10.1038\/ncprheum0616.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3185_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/ard.2009.118620","volume":"70","author":"T Sato","year":"2011","unstructured":"Sato T, Konomi K, Fujii R, Aono H, Aratani S, Yagishita N, Araya N, Yudoh K, Beppu M, Yamano Y, Nishioka K, Nakajima T: Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Ann Rheum Dis. 2011, 70: 221-226. 10.1136\/ard.2009.118620.","journal-title":"Ann Rheum Dis"},{"key":"3185_CR7","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/ar2273","volume":"9","author":"EV Tchetina","year":"2007","unstructured":"Tchetina EV, Di Battista JA, Zukor DJ, Antoniou J, Poole AR: Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res Ther. 2007, 9: R75-10.1186\/ar2273.","journal-title":"Arthritis Res Ther"},{"key":"3185_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF00195907","volume":"46","author":"P Bertin","year":"1994","unstructured":"Bertin P, Lapicque F, Payan E, Rigaud M, Bailleul F, Jaeger S, Treves R, Netter P: Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid. Eur J Clin Pharmacol. 1994, 46: 3-7.","journal-title":"Eur J Clin Pharmacol"},{"key":"3185_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2746\/042516409X436286","volume":"41","author":"JC de Grauw","year":"2009","unstructured":"de Grauw JC, van de Lest CH, Brama PA, Rambags BP, van Weeren PR: In vivo effects of meloxicam on inflammatory mediators, MMP activity and cartilage biomarkers in equine joints with acute synovitis. Equine Vet J. 2009, 41: 693-699. 10.2746\/042516409X436286.","journal-title":"Equine Vet J"},{"key":"3185_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/rheumatology\/kei187","volume":"45","author":"SC Mastbergen","year":"2006","unstructured":"Mastbergen SC, Marijnissen AC, Vianen ME, Zoer B, van Roermund PM, Bijlsma JW, Lafeber FP: Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology (Oxford). 2006, 45: 405-413. 10.1093\/rheumatology\/kei187.","journal-title":"Rheumatology (Oxford)"},{"key":"3185_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.annepidem.2004.03.003","volume":"14","author":"D Il'yasova","year":"2004","unstructured":"Il'yasova D, Morrow JD, Ivanova A, Wagenknecht LE: Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography\/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. Ann Epidemiol. 2004, 14: 793-797. 10.1016\/j.annepidem.2004.03.003.","journal-title":"Ann Epidemiol"},{"key":"3185_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G: XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006, 78: 779-787. 10.1021\/ac051437y.","journal-title":"Anal Chem"},{"key":"3185_CR13","volume-title":"R: A Language and Environment for Statistical Computing","author":"R development Core team","year":"2011","unstructured":"R development Core team: R: A Language and Environment for Statistical Computing. 2011, Vienna, Austria: R Foundation for Statistical Computing, ISBN 3-900051-07-0, [http:\/\/www.R-project.org]"},{"key":"3185_CR14","first-page":"251","volume-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","author":"KS Pollard","year":"2005","unstructured":"Pollard KS, Dudoit S, van der Laan MJ: Multiple testing procedures: the multtest package and applications to genomics. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Edited by: Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S. 2005, New York: Springer, 251-272."},{"key":"3185_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/rcm.3331","volume":"22","author":"M Masoodi","year":"2008","unstructured":"Masoodi M, Mir AA, Petasis NA, Serhan CN, Nicolaou A: Simultaneous lipidomic analysis of three families of bioactive lipid mediators leukotrienes, resolvins, protectins and related hydroxy-fatty acids by liquid chromatography\/electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008, 22: 75-83. 10.1002\/rcm.3331.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3185_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1006\/abio.1996.0093","volume":"235","author":"A Margalit","year":"1996","unstructured":"Margalit A, Duffin KL, Isakson PC: Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies. Anal Biochem. 1996, 235: 73-81. 10.1006\/abio.1996.0093.","journal-title":"Anal Biochem"},{"key":"3185_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1054\/plef.2002.0381","volume":"67","author":"M Takabatake","year":"2002","unstructured":"Takabatake M, Hishinuma T, Suzuki N, Chiba S, Tsukamoto H, Nakamura H, Saga T, Tomioka Y, Kurose A, Sawai T, Mizugaki M: Simultaneous quantification of prostaglandins in human synovial cell-cultured medium using liquid chromatography\/tandem mass spectrometry. Prostaglandins Leukot Essent Fatty Acids. 2002, 67: 51-56. 10.1054\/plef.2002.0381.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"3185_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI200318012","volume":"112","author":"LC Bell-Parikh","year":"2003","unstructured":"Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, FitzGerald GA: Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest. 2003, 112: 945-955.","journal-title":"J Clin Invest"},{"key":"3185_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2746\/0425164054530740","volume":"37","author":"R van den Boom","year":"2005","unstructured":"van den Boom R, van de Lest CH, Bull S, Brama RA, van Weeren PR, Barneveld A: Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints. Equine Vet J. 2005, 37: 250-256.","journal-title":"Equine Vet J"},{"key":"3185_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ab.2005.04.042","volume":"346","author":"RC Murphy","year":"2005","unstructured":"Murphy RC, Barkley RM, Zemski Berry K, Hankin J, Harrison K, Johnson C, Krank J, McAnoy A, Uhlson C, Zarini S: Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem. 2005, 346: 1-42. 10.1016\/j.ab.2005.04.042.","journal-title":"Anal Biochem"},{"key":"3185_CR21","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/rcm.2697","volume":"20","author":"M Masoodi","year":"2006","unstructured":"Masoodi M, Nicolaou A: Lipidomic analysis of twenty-seven prostanoids and isoprostanes by liquid chromatography\/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom. 2006, 20: 3023-3029. 10.1002\/rcm.2697.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"3185_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1194\/jlr.M600508-JLR200","volume":"48","author":"MA Gijon","year":"2007","unstructured":"Gijon MA, Zarini S, Murphy RC: Biosynthesis of eicosanoids and transcellular metabolism of leukotrienes in murine bone marrow cells. J Lipid Res. 2007, 48: 716-725.","journal-title":"J Lipid Res"},{"key":"3185_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ab.2007.08.041","volume":"372","author":"H Cao","year":"2008","unstructured":"Cao H, Xiao L, Park G, Wang X, Azim AC, Christman JW, van Breemen RB: An improved LC-MS\/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. Anal Biochem. 2008, 372: 41-51. 10.1016\/j.ab.2007.08.041.","journal-title":"Anal Biochem"},{"key":"3185_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1042\/BST0361055","volume":"36","author":"BH Maskrey","year":"2008","unstructured":"Maskrey BH, O'Donnell VB: Analysis of eicosanoids and related lipid mediators using mass spectrometry. Biochem Soc Trans. 2008, 36: 1055-1059. 10.1042\/BST0361055.","journal-title":"Biochem Soc Trans"},{"key":"3185_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1006\/abio.1994.1057","volume":"216","author":"ME Surette","year":"1994","unstructured":"Surette ME, Odeimat A, Palmantier R, Marleau S, Poubelle PE, Borgeat P: Reverse-phase high-performance liquid chromatography analysis of arachidonic acid metabolites in plasma after stimulation of whole blood ex vivo. Anal Biochem. 1994, 216: 392-400. 10.1006\/abio.1994.1057.","journal-title":"Anal Biochem"},{"key":"3185_CR26","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/art.1780361017","volume":"36","author":"RH Wittenberg","year":"1993","unstructured":"Wittenberg RH, Willburger RE, Kleemeyer KS, Peskar BA: In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases. Arthritis Rheum. 1993, 36: 1444-1450. 10.1002\/art.1780361017.","journal-title":"Arthritis Rheum"},{"key":"3185_CR27","first-page":"S221","volume":"46","author":"A Amin","year":"2002","unstructured":"Amin A, Attur M, Dave M, Leung M, Serhan C, Abramson S: Functional and pharmacogenomic analysis of lipid mediators in human osteoarthritis-affected cartilage [abstract]. Arthritis Rheum. 2002, 46: S221-","journal-title":"Arthritis Rheum"},{"key":"3185_CR28","first-page":"70","volume":"70","author":"SB Abramson","year":"2004","unstructured":"Abramson SB: Inflammation in osteoarthritis. J Rheumatol Suppl. 2004, 70: 70-76.","journal-title":"J Rheumatol Suppl"},{"key":"3185_CR29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2310\/JIM.0b013e31819aaa76","volume":"57","author":"JU Scher","year":"2009","unstructured":"Scher JU, Pillinger MH: The anti-inflammatory effects of prostaglandins. J Investig Med. 2009, 57: 703-708.","journal-title":"J Investig Med"},{"key":"3185_CR30","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1124\/jpet.106.110387","volume":"319","author":"AM Pulichino","year":"2006","unstructured":"Pulichino AM, Rowland S, Wu T, Clark P, Xu D, Mathieu MC, Riendeau D, Audoly LP: Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis. J Pharmacol Exp Ther. 2006, 319: 1043-1050. 10.1124\/jpet.106.110387.","journal-title":"J Pharmacol Exp Ther"},{"key":"3185_CR31","volume-title":"J Leukoc Biol","author":"PC Norris","year":"2011","unstructured":"Norris PC, Reichart D, Dumlao DS, Glass CK, Dennis EA: Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype. J Leukoc Biol. 2011."},{"key":"3185_CR32","first-page":"704","volume":"32","author":"P Marcouiller","year":"2005","unstructured":"Marcouiller P, Pelletier JP, Guevremont M, Martel-Pelletier J, Ranger P, Laufer S, Reboul P: Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis. J Rheumatol. 2005, 32: 704-712.","journal-title":"J Rheumatol"},{"key":"3185_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.20052371","volume":"203","author":"M Chen","year":"2006","unstructured":"Chen M, Lam BK, Kanaoka Y, Nigrovic PA, Audoly LP, Austen KF, Lee DM: Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med. 2006, 203: 837-842. 10.1084\/jem.20052371.","journal-title":"J Exp Med"},{"key":"3185_CR34","doi-asserted-by":"publisher","first-page":"23568","DOI":"10.1074\/jbc.M110.107623","volume":"285","author":"B Zhai","year":"2010","unstructured":"Zhai B, Yang H, Mancini A, He Q, Antoniou J, Di Battista JA: Leukotriene B(4) BLT receptor signaling regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of Ras\/Raf\/ERK\/p42 AUF1 pathway. J Biol Chem. 2010, 285: 23568-23580. 10.1074\/jbc.M110.107623.","journal-title":"J Biol Chem"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3427\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:06:33Z","timestamp":1728385593000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,27]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,8]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1186\/ar3427","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,27]]},"assertion":[{"value":"15 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R123"}}